Exploring background mutational processes to decipher cancer genetic heterogeneity

Abstract Much remains unknown about the progression and heterogeneity of mutational processes in different cancers and their diagnostic and clinical potential. A growing body of evidence supports mutation rate dependence on the local DNA sequence context for various types of mutations. We propose several tools for the analysis of cancer context-dependent mutations, which are implemented in an online computational framework MutaGene. The framework explores DNA context-dependent mutational patterns and underlying somatic cancer mutagenesis, analyzes mutational profiles of cancer samples, identifies the combinations of underlying mutagenic processes including those related to infidelity of DNA replication and repair machinery, and various other endogenous and exogenous mutagenic factors. As a result, the combination of mutagenic processes can be identified in any query sample with subsequent comparison to mutational profiles derived from malignant and benign samples. In addition, mutagen or cancer-specific mutational background models are applied to calculate expected DNA and protein site mutability to decouple relative contributions of mutagenesis and selection in carcinogenesis, thus elucidating the site-specific driving events in cancer. MutaGene is freely available at https://www.ncbi.nlm.nih.gov/projects/mutagene/.

[1]  Steven A. Roberts,et al.  Mutational heterogeneity in cancer and the search for new cancer-associated genes , 2013 .

[2]  D. Brash.  UV Signature Mutations , 2015, Photochemistry and photobiology.

[3]  C. Swanton.  Intratumor heterogeneity: evolution through space and time. , 2012, Cancer research.

[4]  P. Hainaut,et al.  On the origin of G --> T transversions in lung cancer. , 2003, Mutation research.

[5]  J. Mesirov,et al.  The Molecular Signatures Database Hallmark Gene Set Collection , 2015 .

[6]  David T. W. Jones,et al.  Signatures of mutational processes in human cancer , 2013, Nature.

[7]  I. Rogozin,et al.  Theoretical analysis of mutation hotspots and their DNA sequence context specificity. , 2003, Mutation research.

[8]  Serena Nik-Zainal,et al.  Mechanisms underlying mutational signatures in human cancers , 2014, Nature Reviews Genetics.

[9]  Mel Greaves,et al.  Evolutionary determinants of cancer. , 2015, Cancer discovery.

[10]  Nicholas C. Bauer,et al.  The current state of eukaryotic DNA base damage and repair , 2015, Nucleic acids research.

[11]  M. Lynch.  Rate, molecular spectrum, and consequences of human mutation , 2010, Proceedings of the National Academy of Sciences.

[12]  A. Børresen-Dale,et al.  Mutational Processes Molding the Genomes of 21 Breast Cancers , 2012, Cell.

[13]  Shamil R. Sunyaev,et al.  Impact of deleterious passenger mutations on cancer progression , 2012, Proceedings of the National Academy of Sciences.

[14]  J. Mesirov,et al.  The Molecular Signatures Database (MSigDB) hallmark gene set collection. , 2015, Cell systems.

[15]  M. Stratton,et al.  Mutational signatures: the patterns of somatic mutations hidden in cancer genomes , 2014, Current opinion in genetics & development.

[16]  Hanlee P. Ji,et al.  Pan-cancer analysis of the extent and consequences of intratumor heterogeneity , 2015, Nature Medicine.

[17]  A. Panchenko,et al.  Annotating Mutational Effects on Proteins and Protein Interactions: Designing Novel and Revisiting Existing Protocols. , 2017, Methods in molecular biology.

[18]  Joshua M. Stuart,et al.  The Cancer Genome Atlas Pan-Cancer analysis project , 2013, Nature Genetics.

[19]  Dietrich Lehmann,et al.  Nonsmooth nonnegative matrix factorization (nsNMF) , 2006, IEEE Transactions on Pattern Analysis and Machine Intelligence.

[20]  Serena Nik-Zainal,et al.  A mutational signature in gastric cancer suggests therapeutic strategies , 2015, Nature Communications.

[21]  Xavier Castells,et al.  MutSpec: a Galaxy toolbox for streamlined analyses of somatic mutation spectra in human and mouse cancer genomes , 2016, BMC Bioinformatics.

[22]  B. Vogelstein,et al.  Variation in cancer risk among tissues can be explained by the number of stem cell divisions , 2015, Science.

[23]  Faraz Hach,et al.  Spatial genomic heterogeneity within localized, multifocal prostate cancer , 2015, Nature Genetics.

[24]  Gregory D. Schuler,et al.  Database resources of the National Center for Biotechnology Information: update , 2004, Nucleic acids research.

[25]  A. Morris,et al.  Cancer etiology. Variation in cancer risk among tissues can be explained by the number of stem cell divisions , 2015, BDJ.

[26]  Morris Swertz,et al.  Genome-wide patterns and properties of de novo mutations in humans , 2015, Nature Genetics.

[27]  Bin Tean Teh,et al.  Mutation signatures implicate aristolochic acid in bladder cancer development , 2015, Genome Medicine.

[28]  A. Agrawal,et al.  Low Genetic Quality Alters Key Dimensions of the Mutational Spectrum , 2016, PLoS biology.

[29]  Subhajyoti De,et al.  The landscape of somatic mutations in protein coding genes in apparently benign human tissues carries signatures of relaxed purifying selection , 2016, Nucleic acids research.

[30]  B. Taylor,et al.  deconstructSigs: delineating mutational processes in single tumors distinguishes DNA repair deficiencies and patterns of carcinoma evolution , 2016, Genome Biology.

[31]  L. Alexandrov,et al.  Understanding mutagenesis through delineation of mutational signatures in human cancer. , 2016, Carcinogenesis.

[32]  Ke Ma,et al.  Balancing Protein Stability and Activity in Cancer: A New Approach for Identifying Driver Mutations Affecting CBL Ubiquitin Ligase Activation. , 2016, Cancer research.

[33]  Steven A. Roberts,et al.  An APOBEC cytidine deaminase mutagenesis pattern is widespread in human cancers , 2013, Nature Genetics.

[34]  N. Socci,et al.  Identifying recurrent mutations in cancer reveals widespread lineage diversity and mutational specificity , 2015, Nature Biotechnology.

[35]  Pablo Tamayo,et al.  Metagenes and molecular pattern discovery using matrix factorization , 2004, Proceedings of the National Academy of Sciences of the United States of America.

[36]  Evan Bolton,et al.  Database resources of the National Center for Biotechnology Information , 2017, Nucleic Acids Res..

[37]  Benjamin J. Raphael,et al.  Mutational landscape and significance across 12 major cancer types , 2013, Nature.

[38]  Mingming Jia,et al.  COSMIC: exploring the world's knowledge of somatic mutations in human cancer , 2014, Nucleic Acids Res..

[39]  Leyla Isik,et al.  Cancer-specific high-throughput annotation of somatic mutations: computational prediction of driver missense mutations. , 2009, Cancer research.

[40]  L. Alexandrov,et al.  Base changes in tumour DNA have the power to reveal the causes and evolution of cancer , 2016, Oncogene.

[41]  Julian Gehring,et al.  SomaticSignatures: inferring mutational signatures from single-nucleotide variants , 2014, bioRxiv.

[42]  D. Haussler,et al.  Phylogenetic estimation of context-dependent substitution rates by maximum likelihood. , 2003, Molecular biology and evolution.

[43]  Rainer Lehtonen,et al.  Background mutation frequency in microsatellite-unstable colorectal cancer. , 2007, Cancer research.

[44]  Zhongming Zhao,et al.  Methylation-dependent transition rates are dependent on local sequence lengths and genomic regions. , 2007, Molecular biology and evolution.

[45]  Jessica Zucman-Rossi,et al.  Exome sequencing of hepatocellular carcinomas identifies new mutational signatures and potential therapeutic targets , 2015, Nature Genetics.

[46]  M. Olivier,et al.  Impact of mutant p53 functional properties on TP53 mutation patterns and tumor phenotype: lessons from recent developments in the IARC TP53 database , 2007, Human mutation.

[47]  M. Lynch,et al.  Asymmetric Context-Dependent Mutation Patterns Revealed through Mutation-Accumulation Experiments. , 2015, Molecular biology and evolution.

[48]  Luciano Milanesi,et al.  Computational analysis of mutation spectra , 2003, Briefings Bioinform..

[49]  A. Børresen-Dale,et al.  TP53 mutations in human cancers: functional selection and impact on cancer prognosis and outcomes , 2007, Oncogene.

[50]  William H. Bisson,et al.  Causes of genome instability: the effect of low dose chemical exposures in modern society. , 2015, Carcinogenesis.

[51]  G. Pfeifer,et al.  Mutational spectra of human cancer , 2009, Human Genetics.

[52]  Gary D Bader,et al.  Computational approaches to identify functional genetic variants in cancer genomes , 2013, Nature Methods.

[53]  Subhajyoti De,et al.  Activation induced deaminase mutational signature overlaps with CpG methylation sites in follicular lymphoma and other cancers , 2016, Scientific Reports.

[54]  M. Stratton,et al.  Deciphering Signatures of Mutational Processes Operative in Human Cancer , 2013, Cell reports.